Mathematics
Design
100%
Dose
92%
Clinical Trials
89%
Dose Finding
87%
Toxicity
71%
Phase I Trial
49%
Oncology
43%
Efficacy
41%
Drugs
39%
Continual Reassessment Method
27%
Cancer
26%
Biomarkers
25%
Operating Characteristics
24%
Simulation Study
21%
Maximum Tolerated Dose
21%
Bayesian Design
21%
Immunotherapy
18%
Therapy
18%
Model
18%
Randomisation
16%
Drop out
14%
Historical Data
14%
Evaluate
13%
Bayesian Model Averaging
12%
Missing Data
12%
Subgroup
11%
Bayesian Hierarchical Model
11%
Interval
11%
Group Sequential
11%
Treatment Effects
10%
Covariates
10%
Performance
10%
Randomized Clinical Trial
10%
Schedule
9%
Estimate
9%
Progression
9%
Decision Rules
8%
Pediatrics
8%
Adaptive Design
8%
Random Effects
8%
Monitoring
8%
Methodology
7%
Bayesian Analysis
7%
Model-based Design
7%
Decision Making
7%
Model-based
7%
Mediation
7%
Strategy
6%
Data Augmentation
6%
Latent Class
6%
Medicine & Life Sciences
Maximum Tolerated Dose
56%
Clinical Trials, Phase I
44%
Clinical Trials
42%
Neoplasms
35%
Immunotherapy
30%
Phase II Clinical Trials
30%
Glioblastoma
26%
Therapeutics
23%
Progression-Free Survival
22%
Endometrial Neoplasms
21%
Sample Size
20%
Bayes Theorem
18%
Biomarkers
18%
Survival
18%
Glioma
17%
Chronic Pancreatitis
17%
Temozolomide
14%
Drug Development
14%
Head and Neck Neoplasms
14%
Pancreatitis
13%
Software
13%
Randomized Controlled Trials
13%
Pediatrics
13%
Radiation
12%
Random Allocation
12%
Safety
11%
Radiotherapy
11%
Bevacizumab
10%
Pharmaceutical Preparations
10%
Ovarian Neoplasms
9%
Ependymoma
9%
Brain Neoplasms
9%
Appointments and Schedules
8%
Logistic Models
7%
Colorectal Neoplasms
7%
Risk Assessment
7%
Breast Neoplasms
7%
Skeleton
7%
Cancer Survivors
7%
Decision Making
7%
Adenoviridae
7%
Pancreatic Neoplasms
7%
Drug Therapy
6%
Datasets
6%
Early Detection of Cancer
6%
Lapatinib
6%
Clinical Studies
6%
Biosimilar Pharmaceuticals
6%
Transcriptome
6%